These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 12527902)
1. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma. Fukuma M; Okita H; Hata J; Umezawa A Oncogene; 2003 Jan; 22(1):1-9. PubMed ID: 12527902 [TBL] [Abstract][Full Text] [Related]
2. The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors. Nishimori H; Sasaki Y; Yoshida K; Irifune H; Zembutsu H; Tanaka T; Aoyama T; Hosaka T; Kawaguchi S; Wada T; Hata J; Toguchida J; Nakamura Y; Tokino T Oncogene; 2002 Nov; 21(54):8302-9. PubMed ID: 12447693 [TBL] [Abstract][Full Text] [Related]
3. Induction of tenascin-C by tumor-specific EWS-ETS fusion genes. Watanabe G; Nishimori H; Irifune H; Sasaki Y; Ishida S; Zembutsu H; Tanaka T; Kawaguchi S; Wada T; Hata J; Kusakabe M; Yoshida K; Nakamura Y; Tokino T Genes Chromosomes Cancer; 2003 Mar; 36(3):224-32. PubMed ID: 12557222 [TBL] [Abstract][Full Text] [Related]
4. EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro. Kovar H; Aryee DN; Jug G; Henöckl C; Schemper M; Delattre O; Thomas G; Gadner H Cell Growth Differ; 1996 Apr; 7(4):429-37. PubMed ID: 9052984 [TBL] [Abstract][Full Text] [Related]
5. A new member of the ETS family fused to EWS in Ewing tumors. Peter M; Couturier J; Pacquement H; Michon J; Thomas G; Magdelenat H; Delattre O Oncogene; 1997 Mar; 14(10):1159-64. PubMed ID: 9121764 [TBL] [Abstract][Full Text] [Related]
6. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein. Hahm KB; Cho K; Lee C; Im YH; Chang J; Choi SG; Sorensen PH; Thiele CJ; Kim SJ Nat Genet; 1999 Oct; 23(2):222-7. PubMed ID: 10508522 [TBL] [Abstract][Full Text] [Related]
7. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Sorensen PH; Lessnick SL; Lopez-Terrada D; Liu XF; Triche TJ; Denny CT Nat Genet; 1994 Feb; 6(2):146-51. PubMed ID: 8162068 [TBL] [Abstract][Full Text] [Related]
8. EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene. Thompson AD; Braun BS; Arvand A; Stewart SD; May WA; Chen E; Korenberg J; Denny C Oncogene; 1996 Dec; 13(12):2649-58. PubMed ID: 9000139 [TBL] [Abstract][Full Text] [Related]
9. Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids. Athanasiou M; LeGallic L; Watson DK; Blair DG; Mavrothalassitis G Cancer Gene Ther; 2000 Aug; 7(8):1188-95. PubMed ID: 10975680 [TBL] [Abstract][Full Text] [Related]
10. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene. Lessnick SL; Braun BS; Denny CT; May WA Oncogene; 1995 Feb; 10(3):423-31. PubMed ID: 7845667 [TBL] [Abstract][Full Text] [Related]
11. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors. Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038 [TBL] [Abstract][Full Text] [Related]
12. A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Jeon IS; Davis JN; Braun BS; Sublett JE; Roussel MF; Denny CT; Shapiro DN Oncogene; 1995 Mar; 10(6):1229-34. PubMed ID: 7700648 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias. Yi H; Fujimura Y; Ouchida M; Prasad DD; Rao VN; Reddy ES Oncogene; 1997 Mar; 14(11):1259-68. PubMed ID: 9178886 [TBL] [Abstract][Full Text] [Related]
14. Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein. Spahn L; Siligan C; Bachmaier R; Schmid JA; Aryee DN; Kovar H Oncogene; 2003 Oct; 22(44):6819-29. PubMed ID: 14534527 [TBL] [Abstract][Full Text] [Related]
15. EWS/Fli-1 chimeric protein is a transcriptional activator. Ohno T; Rao VN; Reddy ES Cancer Res; 1993 Dec; 53(24):5859-63. PubMed ID: 7503813 [TBL] [Abstract][Full Text] [Related]
16. EWS/ETS fusions activate telomerase in Ewing's tumors. Takahashi A; Higashino F; Aoyagi M; Yoshida K; Itoh M; Kyo S; Ohno T; Taira T; Ariga H; Nakajima K; Hatta M; Kobayashi M; Sano H; Kohgo T; Shindoh M Cancer Res; 2003 Dec; 63(23):8338-44. PubMed ID: 14678994 [TBL] [Abstract][Full Text] [Related]
17. The EWS/FLI1 oncogenic protein inhibits expression of the Wnt inhibitor DICKKOPF-1 gene and antagonizes beta-catenin/TCF-mediated transcription. Navarro D; Agra N; Pestaña A; Alonso J; González-Sancho JM Carcinogenesis; 2010 Mar; 31(3):394-401. PubMed ID: 20019092 [TBL] [Abstract][Full Text] [Related]
18. Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing's sarcoma EWS/FLI1 fusion gene. Sorensen PH; Shimada H; Liu XF; Lim JF; Thomas G; Triche TJ Cancer Res; 1995 Mar; 55(6):1385-92. PubMed ID: 7882340 [TBL] [Abstract][Full Text] [Related]
19. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance. Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047 [TBL] [Abstract][Full Text] [Related]
20. Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma. Lin PP; Brody RI; Hamelin AC; Bradner JE; Healey JH; Ladanyi M Cancer Res; 1999 Apr; 59(7):1428-32. PubMed ID: 10197607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]